Breakthrough Business Models

Breakthrough Business Models

Drug Development for Rare and Neglected Diseases and Individualized Therapies : Workshop Summary

eBook - 2008
Rate this:
The process for developing new drug and biologic products is extraordinarily expensive and time-consuming. Although large pharmaceutical companies may be able to afford the cost of development because they can expect a large return on investment, organizations developing drugs to treat rare and neglected diseases are unable to rely on such returns.
On June 23, 2008, the Institute of Medicine's Forum on Drug Discovery, Development, and Translation held a public workshop, "Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies," which sought to explore new and innovative strategies for developing drugs for rare and neglected diseases.
Publisher: Washington : National Academies Press, 2008
Copyright Date: ©2009
ISBN: 9780309120890
Branch Call Number: Electronic book
Characteristics: 1 online resource (151 pages)
Additional Contributors: ProQuest (Firm)


From the critics

Community Activity


Add a Comment

There are no comments for this title yet.


Add Age Suitability

There are no ages for this title yet.


Add a Summary

There are no summaries for this title yet.


Add Notices

There are no notices for this title yet.


Add a Quote

There are no quotes for this title yet.

Explore Further


Subject Headings


Find it at MCL

To Top